News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis Inc
(NQ:
PSNL
)
4.920
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis Inc
< Previous
1
2
3
4
5
6
7
Next >
Personalis: Q3 Earnings Insights
November 07, 2023
Via
Benzinga
Personalis Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer
October 26, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Third Quarter 2023 Financial Results
October 24, 2023
From
Personalis, Inc.
Via
Business Wire
Analyst Ratings for Personalis
May 04, 2023
Via
Benzinga
Recap: Personalis Q1 Earnings
May 03, 2023
Via
Benzinga
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
Earnings Outlook For Personalis
November 06, 2023
Via
Benzinga
Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
October 21, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
October 19, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
October 18, 2023
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Friday's session saw 112 companies set new 52-week lows.
Via
Benzinga
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
August 29, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 24, 2023
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
Personalis Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at Upcoming Investor Conferences
August 01, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Second Quarter 2023 Financial Results
July 25, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics
June 26, 2023
From
Personalis, Inc.
Via
Business Wire
Dr. Kenneth J. Widder Joins Personalis Board of Directors
June 13, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
May 30, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
May 16, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Reports First Quarter 2023 Financial Results
May 03, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
May 02, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce First Quarter 2023 Financial Results
April 19, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
March 22, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
March 07, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Appoints Christopher Hall as Chief Executive Officer
March 02, 2023
From
Personalis, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.